Clinical Trials Directory

Trials / Unknown

UnknownNCT05256511

COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic

Incidence of Ventilator-associated Lower Respiratory Tract Infections Among Patients With SARS-CoV-2 Infection Throughout the First and the Second Wave of the Pandemic: a European Comparative Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,136 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicenter observational retrospective cohort study aiming at comparing the incidence of ventilator-associated lower respiratory tract infections between COVID-19 patients from the first and the second wave of the pandemic.

Detailed description

CoVAPid2 is a multicenter retrospective observational cohort study aiming at comparing the incidence of ventilator-associated lower respiratory tract infections between COVID-19 patients from the first and the second wave of the pandemic. Patients with confirmed SARS-CoV-2 community-acquired pneumonia and receiving invasive mechanical ventilation for more than 48h in the participating ICUs from the start of COVID pandemic are eligible for this study. Consecutive patients will be included from the beginning of the first wave (starting on 01-01-2020, data already collected in the CoVAPid1 study) and the second wave (starting on 10-01-2020). 10-20 patients per wave will be included in each center. VAT and VAP are defined using clinical, radiological and quantitative microbiological criteria.

Conditions

Timeline

Start date
2021-11-15
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2022-02-25
Last updated
2022-07-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05256511. Inclusion in this directory is not an endorsement.